Dimki Patel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dimki Patel has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Anna Särnefält
Manufacturing & Supply Chain, Coalition for Epidemic Preparedness Innovations, Askekroken 11, 0277 Oslo, Norway
1 shared publication - Gene Malin
Coalition for Epidemic Preparedness Innovations, Askekroken 11, 0277 Oslo, Norway
1 shared publication - June Kim
Manufacturing & Supply Chain, Coalition for Epidemic Preparedness Innovations, Askekroken 11, 0277 Oslo, Norway
1 shared publication - Ramin Sabet-Azad
Manufacturing & Supply Chain, Coalition for Epidemic Preparedness Innovations, Askekroken 11, 0277 Oslo, Norway
1 shared publication - Syed Hassan Askary
Regulatory Affairs, Coalition for Epidemic Preparedness Innovations, Askekroken 11, 0277 Oslo, Norway
1 shared publication
Latest Publications
- Open Access
Fast-Tracking Vaccine Manufacturing: CEPI’s Rapid Response Framework for the 100 Days Mission
CEPI (the Coalition for Epidemic Preparedness Innovation)’s CMC rapid response framework is developed to support accelerated vaccine development, manufacturing, and roll-out for various outbreak scenarios to achieve the 100 Days Mission. The framework outlines coordinated deliverables across five functional areas: manufacturing processes, formulation, analytics, supply chain, and facilities. It could serve as a tool to streamline CMC and the related activities for rapid vaccine development, identify areas for improvement and innovation, and assess preparedness for the outbreak response. The framework emphasizes the importance of thorough preparation during interpandemic periods as the foundation for the 100 Days Mission and for gaining the confidence of health authorities and the public in vaccines.
Open AccessFast-Tracking Vaccine Manufacturing: CEPI’s Rapid Response Framework for the 100 Days Mission
CEPI (the Coalition for Epidemic Preparedness Innovation)’s CMC rapid response framework is developed to support accelerated vaccine development, manufacturing, and roll-out for various outbreak scenarios to achieve the 100 Days Mission. The framework outlines coordinated deliverables across five functional areas: manufacturing processes, formulation, analytics, supply chain, and facilities. It could serve as a tool to streamline CMC and the related activities for rapid vaccine development, identify areas for improvement and innovation, and assess preparedness for the outbreak response. The framework emphasizes the importance of thorough preparation during interpandemic periods as the foundation for the 100 Days Mission and for gaining the confidence of health authorities and the public in vaccines.